| AMPK | AMP-activated protein kinase |
| Aib | α-aminoisobutyric acid |
| ActRII | activin type II receptor |
| AMYR | amylin receptor |
| CB1R | cannabinoid type 1 receptor |
| cAMP | cyclic adenosine monophosphate |
| CTR | calcitonin receptor |
| EC50 | half-maximal effective concentration |
| Fc | fragment crystallizable region (of an antibody) |
| GABA | gamma-aminobutyric acid |
| GPCR | G protein-coupled receptor |
| ERK | extracellular signal-regulated kinase |
| Gi/o | inhibitory G protein alpha subunits (Gi and Go) |
| Gs | stimulatory G protein alpha subunit |
| K_D (Kd) | equilibrium dissociation constant |
| Ki | inhibition constant |
| GLP-1R | Glucagon-like peptide-1 receptor |
| GIPR | Glucose-dependent insulinotropic polypeptide receptor |
| GCGR | Glucagon receptor |
| GDF15 | Growth differentiation factor 15 |
| IC50 | half-maximal inhibitory concentration |
| LEPR | Leptin receptor |
| MC1R | melanocortin-1 receptor |
| MC4R | Melanocortin-4 receptor |
| MAOI | monoamine oxidase inhibitor |
| MEN 2 | multiple endocrine neoplasia syndrome type 2 |
| MTC | Medullary thyroid carcinoma |
| NFAT | nuclear factor of activated T cells |
| NE | Norepinephrine |
| NTS | nucleus tractus solitarius |
| nM | nanomolar |
| pM | picomolar |
| µM | micromolar |
| POMC | pro-opiomelanocortin |
| RAMP | Receptor activity-modifying protein |
| SGLT2 | sodium–glucose cotransporter 2 |
| GFRAL | GDNF family receptor alpha-like |
| RET | RET receptor tyrosine kinase |